探索三阴性乳腺癌干细胞和瘤微环境之间的相互作用,以制定有效的治疗策略
Zhuoling Zou1, Tinglan Luo2, Xinyuan Wang3
1Queen Mary College, Nanchang University, Nanchang, Jiangxi, China.
Journal of cellular physiology
|May 29, 2024
概括
三重阴性乳腺癌 (TNBC) 是具有侵略性的. 向瘤微环境 (TME) 和乳腺癌干细胞 (BCSCs) 提供了新的治疗策略,以对抗TNBC进展和耐药性.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有有限治疗选择的侵袭性恶性瘤.
- 乳腺癌干细胞 (BCSCs) 驱动TNBC的瘤生长,转移和耐药性.
- 瘤微环境 (TME) 关键调节BCSCs,影响TNBC的进展.
研究的目的:
- 审查BCSC和TNBC进展之间的复杂关系.
- 阐明TME在监管BCSC和TNBC发展中的作用.
- 讨论针对TNBC治疗的BCSC-TME轴的治疗策略.
主要方法:
- 文献审查侧重于临床前和临床研究.
- 分析TME内部的通信网络.
- 综合目前对TNBC中BCSC-TME相互作用的理解.
主要成果:
- BCSCs是TNBC攻击性,转移和治疗耐药性的关键驱动因素.
- 由免疫细胞,CAF和细胞外基质组成的TME提供了支持BCSC生存和功能的.
- 针对TME消除BCSC位或修改BCSC改变TME是有希望的治疗途径.
结论:
- BCSCs和TME之间的相互作用是TNBC病原体的核心.
- 调节TME具有改善TNBC治疗结果的巨大潜力.
- 准BCSC及其相关的微环境是TNBC的一个可行的临床策略.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K


